title: Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia.
abstract: Mortality increases when acute coronary syndromes are complicated by stress-induced hyperglycemia. Early pulse wave reflection can augment central aortic systolic blood pressure and increase left ventricular strain. Altered pulse wave reflection may contribute to the increase in cardiac risk during acute hyperglycemia. Chronic ascorbic acid (AA) supplementation has recently been shown to reduce pulse wave reflection in diabetes. We investigated the in vivo effects of acute hyperglycemia, with and without AA pretreatment, on pulse wave reflection and arterial hemodynamics. Healthy male volunteers were studied. Peripheral blood pressure (BP) was measured at the brachial artery, and the SphygmoCor pulse wave analysis system was used to derive central BP, the aortic augmentation index (AIx; measure of systemic arterial stiffness), and the time to pulse wave refection (Tr; measure of aortic distensibility) from noninvasively obtained radial artery pulse pressure (PP) waveforms. Hemodynamics were recorded at baseline and then every 30 min during a 120-min systemic hyperglycemic clamp (14 mmol/l). The subjects, studied on two separate occasions, were randomized in a double-blind, crossover manner to placebo or 2 g intravenous AA before the initiation of hyperglycemia. During hyperglycemia, AIx increased and Tr decreased. Hyperglycemia did not change peripheral PP but did magnify central aortic PP and diminished the normal physiological amplification of PP from the aorta to the periphery. Pulse wave reflection, as assessed from peripheral pulse wave analysis, is enhanced during acute hyperglycemia. Pretreatment with AA prevented the hyperglycemia-induced hemodynamic changes. By protecting hemodynamics during acute hyperglycemia, AA may have therapeutic use.
authors.affiliation: Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast BT12 6BA, Northern Ireland. brian@mullan99.fsnet.co.uk
authors.forename: Brian A
authors.initials: BA
authors.lastname: Mullan
authors.forename: Ciaran N
authors.initials: CN
authors.lastname: Ennis
authors.forename: Howard J P
authors.initials: HJ
authors.lastname: Fee
authors.forename: Ian S
authors.initials: IS
authors.lastname: Young
authors.forename: David R
authors.initials: DR
authors.lastname: McCance
mesh_terms: D000208:Acute Disease; D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D001011:Aorta / Q000503:physiopathology; D001158:Arteries / Q000503:physiopathology*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001916:Brachial Artery / Q000187:drug effects / Q000503:physiopathology; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004548:Elasticity; D015309:Glucose Clamp Technique; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D007275:Injections, Intravenous; D008297:Male; D011674:Pulse; D017534:Radial Artery / Q000503:physiopathology
chemical_list: D000975:Antioxidants; D001205:Ascorbic Acid